AI and new tests aim to spot silent liver damage before It's too late
NCT ID NCT04666402
Summary
This study is testing a new approach to diagnose liver scarring (fibrosis) earlier. Researchers will combine information from standard blood tests, new biomarkers, and gut bacteria analysis with artificial intelligence. The goal is to create a better tool to identify patients with serious liver damage in community clinics, so fewer people need to be referred to hospital specialists.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Manchester University NHS Foundation Trust
RECRUITINGManchester, Greater Manchester, M13 9WL, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.